Press Release – New York, NY – October 15, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery …
Sichenzia Ross Ference Carmel LLP represents Calidi Biotherapeutics, Inc. in $5.1 Million At The Market Offering
Press Release – New York, NY – October 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it previously represented Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (the “Company”), a …
Sichenzia Ross Ference Carmel LLP Represents Aegis Capital Corp. in the $8.2 Million Private Placement of SOBRsafe, Inc.
New York, NY - October 9, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Aegis Capital Corp. as exclusive placement agent for the $8.2 million private placement from …
Sichenzia Ross Ference Carmel LLP represents A2Z Cust2Mate Solutions Corp. in $4 Million Registered Direct Offering
Press Release – New York, NY – October 2, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global leader in innovative …
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $5.0 Million Offering
Press Release – New York, NY – October 1, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage …
Sichenzia Ross Ference Carmel LLP Represents Innovation Beverage Group Limited in Closing of $5.4 Million Initial Public Offering
Press Release – New York, NY – October 1, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Innovation Beverage Group Limited (Nasdaq: IBG), a developer, manufacturer, …